Top RheumPAC donors attended a virtual legislative update and Q&A with Rep. Ami Bera (D-Calif.) shortly after the release of House Democrats’ $3 trillion coronavirus response plan.
AMA House of Delegates Meeting Postponed Due to COVID-19, Advocacy Efforts Continue
Due to the COVID-19 pandemic, the AMA House of Delegates meeting planned for June has been canceled, but the ACR’s delegation remains ready to advocate for both ongoing and new rheumatology issues, including patient protections in step therapy, prior authorization and expansion of telehealth.
Fellowship Training Goes Virtual: COVID-19 Pandemic Creates Training Challenges
With telemedicine platforms and Zoom calls, technology is playing a large role in how rheumatology fellows are seeing patients and participating in lectures and conferences…
Apremilast Most Helpful for Mild to Moderate Psoriatic Arthritis
Recent research examined the use of apremilast in patients with psoriatic arthritis using the Clinical Disease Activity in Psoriatic Arthritis (cDAPSA) measurement. The findings suggest patients with moderate disease activity at baseline benefit most from the treatment…
Unprecedented Cluster of Hyperinflammatory Shock in Kids in U.K., possibly Linked to COVID-19
NEW YORK (Reuters Health)—Cases of a rare hyperinflammatory syndrome believed to be linked to novel coronavirus continue to be reported around the world. During a 10-day period in mid-April, clinicians in London treated an “unprecedented” cluster of eight children with hyperinflammatory shock, who presented to Evelina London Children’s Hospital pediatric intensive care unit (ICU), triggering…
U.S. to Tell Doctors to Report Cases of COVID-19 Inflammatory Syndrome in Kids
CHICAGO (Reuters)—On May 13, U.S. health officials said they will issue an alert telling doctors to report cases of a rare life-threatening inflammatory syndrome associated with COVID-19 in children to their state and local health departments. The alert from the U.S. Centers for Disease Control and Prevention (CDC) will be released on Wednesday or Thursday,…
Hydroxychloroquine for COVID-19 Fails Another Test
(Reuters)—The malaria treatment repeatedly championed by U.S. President Donald Trump as a game changer in the fight against the novel coronavirus has again failed to show a benefit in patients hospitalized with COVID-19, according to a recent study. Although the study published in The New England Journal of Medicine had certain limitations, doctors report that…
The Value of Measuring Value
In light of a new reporting framework that will be available in 2021, Lisa Suter, MD, describes the importance of quality measures for measuring value and improving patient care.
Rheumatology in a COVID & Post-COVID World
Jane’s* hands and wrists had been swollen and painful for about eight weeks. Lab findings in the ambulatory consult that came to our office revealed a cyclic citrullinated peptide antibody count >250 u/mL. We all know where this story goes, including how important the early treatment window is. Our clinic reviews all consults and tries…
Capitol Hill Rheumatology Advocacy Goes Virtual
ACR volunteer leaders and staff will convene more than 100 meetings via teleconference with Congressional leaders on May 22, addressing rheumatology provider solvency and patient access to care amidst the COVID-19 pandemic.
- « Previous Page
- 1
- …
- 95
- 96
- 97
- 98
- 99
- …
- 325
- Next Page »